908 Devices Inc.

Last updated September 27, 2026

Organization details

Legal name
908 Devices Inc.
Ownership
Public
Status
Active
Headquarters country
United States
Ticker symbol
MASS
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001555279

Board of directors

Chief executives

Kevin J. Knopp · President and CEO
Dates unknown

Board connections

5 of this board's directors also sit on 9 other boards.

Network of 908 Devices Inc.'s board connections Amneal Pharmaceuticals Inc. Amneal Pharmaceuticals... BioLife Solutions Inc. BioLife Solutions Inc. HawkEye 360 Inc. HawkEye 360 Inc. Kardigan Inc. Kardigan Inc. LENZ Therapeutics Inc. LENZ Therapeutics Inc. Quanterix Corporation Quanterix Corporation Repligen Corporation Repligen Corporation Standard BioTools Inc. Standard BioTools Inc. Twist Bioscience Corporation Twist Bioscience Corpo... Anthony Hunt Anthony Hunt Fenel M. Eloi Fenel M. Eloi Jeffrey P. George Jeffrey P. George Keith Crandell Keith Crandell Mark Spoto Mark Spoto 908 Devices Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$9,371,548
57 sales by 6 insiders
Date Insider Transaction Shares Price Value
Sep 24, 2026 AWM Investment Company, Inc. 10% owner Open-market sale −24,000 $11.36 $272,626
Sep 23, 2026 AWM Investment Company, Inc. 10% owner Open-market sale −1,000 $11.25 $11,250
Sep 17, 2026 Kenneweg John Officer (SVP, Sales & Product Marketing) Option exercise +5,257 $0.96 $5,047
Sep 17, 2026 Kenneweg John Officer (SVP, Sales & Product Marketing) Open-market sale −5,257 $10.22 $53,727
Sep 16, 2026 Kenneweg John Officer (SVP, Sales & Product Marketing) Option exercise +21,399 $0.96 $20,543
Sep 16, 2026 Kenneweg John Officer (SVP, Sales & Product Marketing) Open-market sale −21,399 $10.11 $216,344
Sep 15, 2026 Kenneweg John Officer (SVP, Sales & Product Marketing) Option exercise +1,000 $0.96 $960
Sep 15, 2026 Kenneweg John Officer (SVP, Sales & Product Marketing) Open-market sale −1,000 $10.00 $10,000
Sep 2, 2026 Christopher D. Brown Director Open-market sale −30,000 $10.58 $317,400
Aug 25, 2026 Griffith Joseph H. IV Officer (Chief Financial Officer) Open-market sale −11,459 $10.95 $125,476
Aug 21, 2026 AWM Investment Company, Inc. 10% owner Open-market sale −41,578 $10.61 $441,159
Aug 20, 2026 AWM Investment Company, Inc. 10% owner Open-market sale −8,422 $10.52 $88,638
Aug 17, 2026 Kevin J. Knopp Director, Officer (President and CEO) Open-market sale −20,000 $10.35 $207,000
Aug 13, 2026 Kevin J. Knopp Director, Officer (President and CEO) Open-market sale −7,622 $10.06 $76,677
Aug 12, 2026 Kevin J. Knopp Director, Officer (President and CEO) Open-market sale −2,747 $10.07 $27,662

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.